Shilpa Medicare Limited
₹415.9-1.00%Apr 13, 3:45 PM IST
SHILPAMED•Health Technology•Pharmaceuticals: Major
Current Price
₹415.9-1.00%
Apr 13, 3:45 PM ISTMarket Cap₹8,212.48 Cr
Market Cap₹8,212.48 Cr
Business Overview
Shilpa Medicare Limited operates through 4 main business divisions including Active Pharmaceutical Ingredients (APIs), Formulations, Biologicals, Contract Development and Manufacturing Organization (CDMO).
Business Hierarchy Structure for Shilpa Medicare Limited
- Shilpa Medicare Limited
- Active Pharmaceutical Ingredients (APIs)
- Oncology APIs
- Non-Oncology APIs
- Peptides
- Polymers
- Nutraceuticals
- Formulations
- Oral Solids (Tablets & Capsules)
- Liquid Injections
- Dry Powder Injectables
- Lyophilised Injectables
- Novel Drug Delivery Systems (NDDS)
- Orally Disintegrating Films (ODFs)
- Transdermal Systems (TDS)
- Oncology Formulations
- NAFLD Treatment Products
- SMLNUD07 (Nor UDCA)
- Transdermal Patches
- Rotigotine Transdermal Patch
- Topical Formulations
- Topical Lotion for Androgenic Alopecia
- Innovative Formulations
- Dr. CLOT Spray (Tranexamic Acid)
- Oncology Injectables
- Pemetrexed Injection (NDA)
- ODF Products
- Betahistine ODF
- Tadalafil ODF
- Bilastine ODF
- Biologicals
- Mammalian Products
- Microbial Products
- Fermentation Products
- Biosimilars
- Adalimumab
- Aflibercept
- Abatacept
- Etanercept
- Pembrolizumab
- Nivolumab
- Recombinant Human Albumin
- Contract Development and Manufacturing Organization (CDMO)
- Small Molecule API Development & Manufacturing
- Large Molecule Development & Manufacturing
- Drug Substance Development
- Drug Product Development
- Custom Synthesis
- Process Development
- Fill-Finish, Labeling, Packaging
- Active Pharmaceutical Ingredients (APIs)